AB
Alexandra Balcom
DELAYED 1 MONTH
Chief Financial Officer; Director
CRESCENT BIOPHARMA, INC.
Nuvalent, Inc.
Filings
3
Companies
2
Latest
Jun 2, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
74
NUVLCLUSTER 4
Nuvalent, Inc.
Alexandra Balcom
Chief Financial Officer
Sale
$1.1M
11,430 sh
Jun 3 8:30 PM
Jun 1, 2026
—
Nuvalent, Inc.
Alexandra Balcom
Chief Financial Officer
Option Exercise
$78.8K
11,430 sh
Jun 3 8:30 PM
Jun 1, 2026
72
NUVLCLUSTER 3
Nuvalent, Inc.
Alexandra Balcom
Chief Financial Officer
Sale
$1.1M
11,430 sh
May 5 8:30 PM
May 1, 2026
—
Nuvalent, Inc.
Alexandra Balcom
Chief Financial Officer
Option Exercise
$37.2K
11,430 sh
May 5 8:30 PM
May 1, 2026